S

Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185

Watchlist Manager
Shanghai Bio-heart Biological Technology Co Ltd
HKEX:2185
Watchlist
Price: 4.34 HKD 1.88% Market Closed
Market Cap: HK$1.1B

Shanghai Bio-heart Biological Technology Co Ltd
Investor Relations

Shanghai Bio-Heart Biological Technology Co., Ltd. engages in the development of cardiovascular devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-12-23. The firm's main businesses are the development and production of interventional cardiovascular devices. The firm's main products include fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The firm's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension.

Show more
Loading
2185
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Li Wang
Executive Chairman of the Board, CEO & GM
No Bio Available
Mr. Yunqing Wang
CFO, Joint Company Secretary & Executive Director
No Bio Available
Ms. Peili Wang
Financial Manager & Executive Director
No Bio Available
Dr. Bradley Stewart Hubbard D.V.M., DVM
Chief Medical Officer
No Bio Available
Ms. Siu Ying Kwok
Joint Company Secretary
No Bio Available
Mr. Tao Cai
Chairperson of the Board of Supervisors & Head of Technology of BRS
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
Room 302, 3/F, Building 4, No.590 Ruiqing Road, East Zhangjiang Hi-Tech Park, Pudong New Area
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett